You are here

Tyrvaya

Oyster Point Laying Off 50 with Focus on Dry Eye Drug Launch

BioSpace

Thu, 06/30/22 - 11:05 am

Oyster Point Pharma

dry eye disease

FDA OKs an inhaled version of smoking cessation drug Chantix — for a common eye disease

Endpoints

Mon, 10/18/21 - 11:57 am

Oyster Point Pharma

dry eye disease